Showing results (311-320 of 374) with videos related to
Sort By:
Pageof 38
Biomaterials|June 30, 2006
The in vitro adsorption of cytokines by polymer-pyrolysed carbonCarol A Howell, Susan R Sandeman, Gary J Phillips, et al.Cancer Immunology, Immunotherapy : CII|October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survivalTyler C Haddad, Songzhu Zhao, Mingjia Li, et al.The Journal of General Virology|June 28, 2022
Differential and defective transcription of koala retrovirus indicates the complexity of host and virus evolutionR E Tarlinton, A R Legione, N Sarker, et al.Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated ColitisHamzah Abu-Sbeih, Faisal S Ali, Abdul Rafeh Naqash, et al.Cancer Immunology, Immunotherapy : CII|March 7, 2020
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, et al.Cancer Immunology, Immunotherapy : CII|April 30, 2020
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, et al.JCSM Communications|July 14, 2025
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J MiceBryan C Remaily, Trang T Vu, Justin Thomas, et al.Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.Pageof 38